Skip to main content

Security report for biogen.hu

Biogen Hungary KFT · Healthcare · Hungary

Low risk. 2 critical or high findings in Email security and SSL/TLS.

Security score

79/100

Risk levelLow

0–100, higher is better. How it is calculated

Biogen Hungary KFT operates as a local branch of the global biotechnology leader Biogen, focusing on developing therapies in neurology, neuropsychiatry, special immunology, and rare diseases. The website reflects a professional corporate presence with clear branding, comprehensive content about their business focus, and a strong emphasis on scientific innovation and patient care. The company targets healthcare professionals, patients, and stakeholders interested in advanced biotechnological solutions. Technically, the site is built on Adobe Experience Manager, uses modern JavaScript libraries like jQuery, and integrates Cookiebot for GDPR-compliant cookie management. Google Analytics and Google Tag Manager are employed for analytics and marketing purposes, with appropriate consent mechanisms in place. Security posture is strong with HTTPS enforced, security headers present, and no visible vulnerabilities or exposed sensitive data. However, explicit security policies and incident response information are not published, which could be improved. Overall, the site is well-structured, mobile-optimized, and trustworthy, supporting Biogen's market position as a leading biotechnology company.

Scanned

NIS2 and GDPR posture

GDPR outside view
83/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

2 findings rated critical or high. Fix these first.

  1. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching biogen.hu

This scan found 18 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
95
Email security
60
DNS health
75
Network security
100
GDPR outside view
83
Average
79

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention biogen.hu, from OffSeq Breach.

No leaked records found

Breach holds no records for biogen.hu right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Biogen Hungary KFT is positioned as an essential entity in the healthcare sector, focusing on biotechnology and pharmaceutical development. The company leverages its global brand to deliver specialized therapies in complex disease areas. The website supports multiple regional domains, indicating a broad international footprint. The business model centers on research-driven innovation, digital health solutions, and patient-centric therapies. While direct contact details are limited, the presence of a contact form and social media channels facilitates stakeholder engagement. The company demonstrates strong compliance with GDPR and cookie regulations, reflecting maturity in privacy practices. No suspicious or unrelated domains are linked, reinforcing the company's focused market presence.

Security posture

The website demonstrates a mature security posture with HTTPS enforced and multiple security headers implemented, including HSTS, X-Content-Type-Options, and Content-Security-Policy. Cookie consent is managed via Cookiebot with blocking mode enabled, ensuring compliance with privacy regulations. The site uses httpOnly cookies to prevent CSRF attacks. No security.txt or vulnerability disclosure policy is found, and no direct security contact emails are provided, which are areas for improvement. No vulnerable libraries or exposed sensitive data were detected in the HTML content. Overall, the security measures align with industry best practices for corporate websites in the healthcare sector.

Recommendations

  1. Publish a dedicated security policy page outlining security frameworks and practices.
  2. Implement and publish a vulnerability disclosure policy or security.txt file.
  3. Provide direct contact channels for security incidents (e.g., security@biogen.hu).
  4. Enhance accessibility features to improve compliance and user experience.
  5. Regularly review and update third-party scripts and libraries to mitigate vulnerabilities.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Biogen Hungary KFT
Description
A Biogen egy vezető globális biotechnológiai vállalat, amely áttörő tudományos vívmányok és kutatások révén a komplex és súlyos betegségek megoldását keresi. A Biogen a neurológia, a neuropszichiátria, a speciális immunológia és a ritka betegségek területén fejleszti a jövő terápiáit, és törekszik arra, hogy a tudományon keresztül szolgálja az emberiséget. Célja, hogy hozzájáruljon egy egészségesebb, fenntarthatóbb és igazságosabb világ megteremtéséhez.
Key services
neurology therapies, neuropsychiatry therapies, special immunology therapies, rare diseases therapies, digital health solutions
Content quality
good
Branding
consistent

Technology

Stack
jQuery 3.6.4, Adobe Helix RUM, Cookiebot, Google Tag Manager, Google Analytics, Video.js
Frameworks
Adobe Experience Manager (AEM)
Platforms
Web
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent with blocking mode
  • CSRF protection cookie (httpOnly)
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Cookiebot session tracker
Marketing tools
Cookiebot
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. Comprehensive cookie consent mechanism implemented with Cookiebot.
  3. Clear corporate branding and consistent design.
  4. Multiple language and regional site links available.
  5. No direct company contact emails or phone numbers found on main pages; contact form present.
  6. No explicit security or incident response policies published.
  7. Use of modern web technologies and Adobe Experience Manager CMS.
  8. Good SEO and metadata implementation.
  9. Social media presence on LinkedIn, Twitter, Facebook, and YouTube.
Technical notes

Notes

The website is built on Adobe Experience Manager CMS, leveraging modern web technologies including jQuery 3.6.4 and Video.js for multimedia content. Cookiebot is integrated for cookie consent management, and Google Tag Manager and Google Analytics are used for tracking and analytics. The site is mobile-optimized with responsive design and includes proper meta tags for SEO. Performance is moderate, with potential for optimization in loading times. Accessibility is basic but could be improved. The technical infrastructure supports a professional corporate presence with scalability for international regional sites.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with biogen.hu. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review biogen.hu.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.